Incurable Blood Cancer Treatment Could Be In Sight

Incurable Blood Cancer Treatment Could Be In Sight

Incurable Blood Cancer Treatment Could Be In Sight
One of the characteristics of Mantle Cell Lymphoma (MCL) is the aggressive over-production of a cell-proliferation protein due to an overactive gene. Now scientists at Tel Aviv University in Israel, in collaboration with industry, have developed a new class of drugs based on RNA interference that can repair or destroy the faulty proteins, bringing closer the day when this incurable blood cancer can be treated.